Douglas McFadden

Center Director & Professor

  • 14517 Citations
  • 63 h-Index
1978 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Douglas McFadden is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Myxoma virus Medicine & Life Sciences
Poxviridae Medicine & Life Sciences
Rabbit Fibroma Virus Medicine & Life Sciences
Viruses Medicine & Life Sciences
Rabbits Medicine & Life Sciences
Proteins Medicine & Life Sciences
Oncolytic Viruses Medicine & Life Sciences
Virus Diseases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1978 2020

Ex Vivo Virotherapy with Myxoma Virus to Treat Cancer

Villa, N., Franco, L. S. & McFadden, D., Jan 1 2020, Methods in Molecular Biology. Humana Press Inc., p. 95-110 16 p. (Methods in Molecular Biology; vol. 2058).

Research output: Chapter in Book/Report/Conference proceedingChapter

Myxoma virus

Genetic characterization of a recombinant myxoma virus in the iberian hare (Lepus granatensis)

Águeda-Pinto, A., Matos, A. L. D., Abrantes, M., Kraberger, S., Risalde, M. A., Gortázar, C., McFadden, D., Varsani, A. & Esteves, P. J., Jun 1 2019, In : Viruses. 11, 6, 530.

Research output: Contribution to journalArticle

Open Access
Myxoma virus

Modifying the Organ Matrix Pre-engraftment: A New Transplant Paradigm?

Yaron, J. R., Kwiecien, J. M., Zhang, L., Ambadapadi, S., Wakefield, D. N., Clapp, W. L., Dabrowski, W., Burgin, M., Munk, B. H., McFadden, D., Chen, H. & Lucas, A. R., Jan 1 2019, In : Trends in Molecular Medicine.

Research output: Contribution to journalReview article

Tissue Survival
Graft Rejection
Organ Transplantation

Myxoma virus M013 protein antagonizes NF-κB and inflammasome pathways via distinct structural motifs

Garg, R. R., Jackson, C. B., Rahman, M., Khan, A. R., Lewin, A. S. & McFadden, D., Jan 1 2019, In : Journal of Biological Chemistry. 294, 21, p. 8480-8489 10 p.

Research output: Contribution to journalArticle

Myxoma virus
Aspartic Acid
Glutamic Acid

Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival

Kellish, P., Shabashvili, D., Rahman, M., Nawab, A., Guijarro, M. V., Zhang, M., Cao, C., Moussatche, N., Boyle, T., Antonia, S., Reinhard, M., Hartzell, C., Jantz, M., Mehta, H. J., McFadden, D., Kaye, F. J. & Zajac-Kaye, M., Apr 29 2019, In : The Journal of clinical investigation. 130

Research output: Contribution to journalArticle

Open Access
Oncolytic Virotherapy
Myxoma virus
Small Cell Lung Carcinoma

Projects 2017 2020